Towana Looney lived with the kidney longer than any other transplant patient had tolerated an organ from a genetically ...

Rutgers Health researchers and other medical scientists involved in a large international study have identified new signs of kidney transplant ... signs of antibody-mediated rejection.

“Antibody-mediated rejection remains a significant challenge in kidney transplantation, with limited safer and effective treatment options currently available. With the potential to be disease ...

Surgeons at NYU Langone Health in New York City had to remove a genetically modified pig kidney from Towana Looney, 53, of ...

in adult kidney transplant recipients diagnosed with late antibody-mediated rejection (AMR). AMR is a leading cause of kidney transplant failure. AMR occurs in kidney transplant recipients when ...

Hyperacute rejection is an antibody-mediated cytotoxic ... in the operating room; the kidney frequently turns black before the surgical team's eyes. Antibody-to-transplant antigens can develop ...

Biogen has announced that it has initiated a late-stage study of felzartamab in adult kidney transplant recipients who have been diagnosed with late antibody-mediated rejection (AMR). The phase 3 ...

“Antibody-mediated rejection remains a significant challenge in kidney transplantation, with limited safer and effective treatment options currently available. With the potential to be disease ...

The phase 3 study will evaluate the efficacy and safety of the investigational drug felzartamab compared to placebo in adult kidney transplant recipients diagnosed with late antibody-mediated ...

The Phase 3 study will evaluate the efficacy and safety of the investigational drug felzartamab compared to placebo in adult kidney transplant recipients diagnosed with late antibody-mediated ...

The Phase 3 study will evaluate the efficacy and safety of the investigational drug felzartamab compared to placebo in adult kidney transplant ... with late antibody-mediated rejection (AMR).